[1] Dyrlund T.F., Poulsen E.T., Scavenius C., Nikolajsen C.L., Thøgersen I.B., Vorum H., andEnghild J.J.Human Cornea Proteome: Identification and Quantitation of the Proteins of the Three Main Layers Including Epithelium, Stroma, and Endothelium. Journal of proteome research, vol. 11, no. 8, pp. 4231-4239, 2012. [2] Güell J.L.,El Husseiny, M.A., Manero, F., Gris, O., and Elies, D. Historical Review and Update of Surgical Treatment for Corneal Endothelial Diseases. Ophthalmology and therapy, vol. 3, pp. 1-15, 2014. [3] Kelliher C., Chakravarti S., Vij N., Mazur S., Stahl P.J., Engler C., Matthaei M., Yu S.M., andJun A.S.A Cellular Model for the Investigation of Fuchs' Endothelial Corneal Dystrophy. Experimental eye research, vol. 93, no. 6, pp. 880-888, 2011. [4] Oie, Y. and Nishida, K.Corneal Regenerative Medicine. Regenerative therapy, vol. 5, pp. 40-45, 2016. [5] Piorkowski A., Nurzynska K., Gronkowska-Serafin, J., Selig, B., Boldak, C., and Reska, D. Influence of Applied Corneal Endothelium Image Segmentation Techniques on the Clinical Parameters. Computerized Medical Imaging and Graphics, vol. 55, pp. 13-27, 2017. [6] Maugeri G., Longo A., D'Amico, A.G., Rasà, D.M., Reibaldi, M., Russo, A., Bonfiglio, V., Avitabile, T., and D'Agata, V. Trophic Effect of PACAP on Human Corneal Endothelium. Peptides, vol. 99, pp. 20-26, 2018. [7] Kymionis G.D., Liakopoulos D.A., Grentzelos M.A., Naoumidi I., Kontadakis G.A., Tsoulnaras K.I., andPetrelli M.K.Mini Descemet Membrane Stripping (M-DMES) in Patients with Fuchs' Endothelial Dystrophy: A New Method. Saudi journal of ophthalmology, vol. 31, no. 4, pp. 275-279, 2017. [8] Yoshihara M., Hara S., Tsujikawa M., Kawasaki S., Hayashizaki Y., Itoh M., Kawaji H., andNishida K.Restricted Presence of POU6F2 in Human Corneal Endothelial Cells Uncovered by Extension of the Promoter-Level Expression Atlas. EBioMedicine, vol. 25, pp. 175-186, 2017. [9] Okumura N., Kakutani K., Inoue R., Matsumoto D., Shimada T., Nakahara M., Kiyanagi Y., Itoh T. and Koizumi N.Generation and Feasibility Assessment of a New Vehicle for Cell-Based Therapy for Treating Corneal Endothelial Dysfunction. PLoS One, vol. 11, no. 6, pp. e0158427, 2016. [10] Katikireddy K.R., Schmedt T., Price M.O., Price F.W., andJurkunas U.V.Existence of Neural Crest-Derived Progenitor Cells in Normal and Fuchs Endothelial Dystrophy Corneal Endothelium. The American Journal of Pathology, vol. 186, no. 10, pp. 2736-2750, 2016. [11] Jay L., Bourget J.M., Goyer B., Singh K., Brunette I., Ozaki T., andProulx S.Characterization of Tissue-Engineered Posterior Corneas using Second-and Third-Harmonic Generation Microscopy. PloS one, vol. 10, no. 4, pp. e0125564, 2015. [12] Riazuddin S.A., Parker D.S., McGlumphy, E.J., Oh, E.C., Iliff, B.W., Schmedt, T., Jurkunas, U., Schleif, R., Katsanis, N., and Gottsch, J.D. Mutations in LOXHD1, A Recessive-Deafness Locus, Cause Dominant Late-Onset Fuchs Corneal Dystrophy. The American Journal of Human Genetics, vol. 90, no. 3, pp. 533-539, 2012. [13] Riazuddin S.A., Vasanth S., Katsanis N., andGottsch J.D.Mutations in AGBL1 Cause Dominant Late-Onset Fuchs Corneal Dystrophy and Alter Protein-Protein Interaction with TCF4. The American Journal of Human Genetics, vol. 93, no. 4, pp. 758-764, 2013. [14] Chandra, K.V. and Murari, B.M.Confocal Corneal Endothelium Dystrophy'S Analysis using Particle Filter. Journal of Engineering Science and Technology, vol. 15, no. 2, pp. 1338-1356, 2020. [15] Chandra, K. and Murari, B.Confocal Corneal Endothelium Dystrophy'S Analysis using a Hybrid Algorithm. Journal of Engineering Science and Technology (JESTEC), vol. 15, no. 5, pp. 3419-3432, 2020. [16] Chandra, K.V. and Murari, B.M.Specular Endothelium Image Analysis with DEM Algorithm. In2021 International Conference on Emerging Smart Computing and Informatics (ESCI), IEEE, pp. 351-356, 2021. [17] Girisha, V. and Chandra, K.V., Machine Intelligence on Confocal Microscope for Detection of Endothelium Layer of Corneal Disease.Proceeding of IJCTER, pp.148-211. |